NLRP3 and metabolic dysfunction-associated steatotic liver disease: In another study, it was confirmed that nucleotide- binding oligomerization-domain protein-like receptor protein (NLRP) 6 and NLRP3 inflammasomes and IL-18 negatively regulate the progression of NAFLD or NASH through gut microbiota modulation [77].